Sophie E. Ter Hark
Nijmegen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
A higher desmethylclomipramine to clomipramine ratio predicts more effectiveness and fewer adverse effects in major depressive disorder.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: August 23, 2024
Genotype-Specific Tricyclic Antidepressant Dosing in Patients With Major Depressive Disorder: A Trial-Based Economic Evaluation.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: June 25, 2024
Correction: A genetic risk score to predict treatment nonresponse in psychotic depression.
Journal: Translational psychiatry
Published: April 26, 2024
The Relationship of Early Sleep Improvement With Response to Pharmacotherapy in Unipolar Psychotic Depression.
Journal: Journal of clinical psychopharmacology
Published: November 06, 2023
A genetic risk score to predict treatment nonresponse in psychotic depression.
Journal: Translational psychiatry
Published: July 14, 2023
Effectiveness of Genotype-Specific Tricyclic Antidepressant Dosing in Patients With Major Depressive Disorder: A Randomized Clinical Trial.
Journal: JAMA network open
Published: May 08, 2023
Biomarkers as predictors of treatment response to tricyclic antidepressants in major depressive disorder: A systematic review.
Journal: Journal of psychiatric research
Published: February 01, 2022
Association of the neutrophil to lymphocyte ratio and white blood cell count with response to pharmacotherapy in unipolar psychotic depression: An exploratory analysis.
Journal: Brain, behavior, & immunity - health
Published: August 23, 2021
The Potential of Polygenic Risk Scores to Predict Antidepressant Treatment Response in Major Depression: A Systematic Review.
Journal: Journal of affective disorders
Published: July 19, 2021
A new genetic locus for antipsychotic-induced weight gain: A genome-wide study of first-episode psychosis patients using amisulpride (from the OPTiMiSE cohort).
Journal: Journal of psychopharmacology (Oxford, England)
Published: March 05, 2020
Last Updated: 09/26/2026